查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1912824

按產品類型、胰島素類型、技術、支付方式、應用、最終用戶和分銷管道分類的管式胰島素幫浦市場—2026-2032年全球預測

Tube Insulin Pumps Market by Product Type, Insulin Type, Technology, Payment Method, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，管式胰島素幫浦市場價值將達到 45.6 億美元，到 2026 年將成長至 50.9 億美元，複合年成長率為 6.26%，到 ​​2032 年將達到 69.8 億美元。

關鍵市場統計數據
基準年 2025 45.6億美元
預計年份：2026年 50.9億美元
預測年份 2032 69.8億美元
複合年成長率 (%) 6.26%

本報告從策略角度概述了管式胰島素幫浦在不斷發展的糖尿病照護模式中的地位，重點介紹了臨床重點、連接期望和設計促進因素。

本報告首先概述了影響導管式胰島素幫浦發展的臨床、技術和商業性因素，並闡述了為何此類設備日益受到臨床醫生、支付者和產品開發商的關注。開篇說明指出了受持續皮下胰島素輸注影響最大的患者群體，強調了人們對連接性和用戶體驗不斷變化的期望，並將設備創新置於糖尿病管理髮展大局的背景下進行分析。

科技的融合、連接方式的不斷發展以及護理模式的轉變，正在重塑管式胰島素治療領域的競爭優勢和患者期望。

管式胰島素幫浦市場格局正經歷著一場變革性的轉變，其促進因素包括技術的融合、監管環境的演變以及醫療服務模式的轉變。結合持續血糖監測和自動胰島素輸注的先進閉合迴路控制系統正從實驗階段走向商業性化應用，推動臨床工作流程和病人期望的改變。同時，速效和超速效胰島素製劑的改進正在重塑輸注策略，縮短胰島素幫浦演算法的起效時間，推動了對精準輸注機制和更先進控制邏輯的需求。

評估美國在2025年實施的累積貿易措施所帶來的營運影響和採購調整

自2025年美國生效的關稅累積效應已在全球醫療設備供應鏈中造成了明顯的摩擦，尤其是在管式胰島素幫浦的零件和成品組件方面。製造商正透過重新審視其上游籌資策略、提高零件標準化程度以及加快討論關鍵零件的近岸外包或雙重採購來應對這一挑戰。這些營運調整旨在最大限度地降低成本成長，同時保持生產的連續性，但這些調整需要在醫療設備品質系統下進行實施和檢驗，因此需要時間。

詳細的細分分析揭示了產品架構、胰島素配方、護理環境、分銷管道、連接選項和支付方式如何相互交織，從而塑造策略重點。

詳細的細分分析揭示了產品類型、胰島素配方、最終用戶、分銷管道、技術、應用模式和支付方式等因素對績效的細微影響。產品差異化至關重要：從商業系統和DIY系統的角度研究閉合迴路泵，發現其透過提供不同程度的自動化和監管，正在改變臨床預期。傳統胰島素幫浦（包括作為人工胰臟系統開發的改良型）在尋求基於成熟設備基礎的漸進式自動化的臨床環境中繼續發揮作用。貼片式胰島素幫浦正成為注重隱蔽性和易用性的患者的選擇，並且正在影響那些無法忍受笨重導管和設備的群體的接受度。

影響全球主要市場監管策略、報銷安排和經銷夥伴的區域趨勢和獨特戰略要務

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢差異顯著，每個地區都存在獨特的監管、報銷、基礎設施和患者行為的考量，這些因素都會影響產品策略和市場推廣方式。在美洲，成熟的臨床生態系統和完善的報銷體系推動了先進的閉合迴路和應用程式整合解決方案的發展，而對國內製造和供應鏈韌性的日益重視則制約了籌資策略。在歐洲市場，強大的臨床應用和多樣化的國家報銷體系並存，這使得在地化的證據產生和針對特定國家的定價策略成為產品推廣的關鍵。

競爭格局洞察：經證實的臨床療效、可互通的生態系統以及策略夥伴關係關係，是管式胰島素幫浦領域領先地位的決定性因素。

管式胰島素幫浦領域的競爭格局由成熟的醫療設備製造商、創新Start-Ups以及來自其他產業、專注於數位醫療和軟體賦能型護理模式的新興參與企業共同塑造。領先的產品開發商透過臨床檢驗、完善的品質體係以及對整合血糖感測器、給藥機制和資料管理工具的互通性平台的投資來實現差異化。醫療設備製造商與胰島素製造商、雲端平台提供者和藥房網路之間的策略聯盟建構了生態系統，創造了超越胰島素幫浦本身的價值，包括用藥依從性計畫、遠端監測服務和人群層面的分析。

為製造商和相關人員提供切實可行且影響深遠的建議，以增強韌性、加速產品推廣，並使產品藍圖與支付方和臨床需求保持一致。

產業領導者應優先考慮以下切實可行的策略，以維持並擴大自身競爭優勢，同時滿足臨床醫師和病患的需求。首先，投資於模組化設備架構和與供應商無關的介面，這可以降低組件特定關稅風險，並實現關鍵組件的快速替換。這種方法有助於增強韌性，並在供應鏈中斷時縮短反應時間。其次，加快互通性舉措，使泵浦能夠與常用的行動應用程式和雲端平台配合使用。這既能確保與藍牙低功耗協定相容以提高電池效率，還能確保在適當情況下與 Wi-Fi 相容以實現持續資料交換。

我們採用透明且可複製的調查方法，結合臨床醫生訪談、設備測試、監管分析和供應鏈映射，為我們的策略洞察提供支援。

本分析的調查方法結合了第一手資料和第二手資料，以確保對臨床、技術和商業性因素進行全面、實證的分析。第一手資料包括對臨床內分泌學家、糖尿病教育者、醫院和診所採購人員以及分銷管道負責人進行結構化訪談，以獲得關於設備易用性、培訓需求和採購重點的第一手資訊。同時，也進行了設備層面的測試和技術審查，評估了不同胰島素製劑和連接方式的兼容性，並專注於電池壽命、劑量準確性和人體工學設計。

本文對策略洞察進行了簡潔扼要的總結，重點闡述如何整合臨床檢驗、互通性和永續性，從而將創新轉化為永續的患者和商業性價值。

總而言之，基於導管的胰島素幫浦正處於一個轉折點，技術創新、連接模式和不斷發展的醫療服務模式正在融合，這既帶來了機遇，也帶來了營運挑戰。閉合迴路系統和應用程式整合解決方案有望改善血糖控制並提升患者便利性，而胰島素製劑的創新和設備的微型化則拓展了選擇範圍，以滿足不同患者的需求。同時，貿易政策的變化和通路碎片化等外部壓力，要求在採購、模組化和與支付方的合作方面進行周全的考量。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的管式胰島素幫浦市場

  • 閉合迴路泵
    • 市售系統
    • DIY系統
  • 傳統泵浦
  • 貼片幫浦

9. 依胰島素類型分類的管式胰島素幫浦市場

  • 快速起效
    • Aspart
    • Glulisine
    • Lispro
  • 超速效型
    • 恐懼
    • 呂姆傑布

10. 依技術分類的管式胰島素幫浦市場

  • 藍牙功能
    • Bluetooth Classic
    • Bluetooth Low Energy
  • 未連接
  • 具備 Wi-Fi 功能

第11章 以支付方式分類的管式胰島素幫浦市場

  • 保險範圍
    • 政府報銷
    • 私人保險
  • 自費

第12章 依應用分類的管式胰島素幫浦市場

  • 應用整合
    • 雲端平台
    • 行動應用
  • 獨立版

第13章 依最終用戶分類的管式胰島素幫浦市場

  • 門診服務
  • 居家照護環境
    • 看護者管理
    • 自我管理
  • 醫院和診所
    • 社區醫院
    • 教學醫院

第14章 依通路分類的管式胰島素幫浦市場

  • 醫院藥房
  • 網路藥房
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房

15. 按地區分類的管式胰島素幫浦市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 依組別分類的管式胰島素幫浦市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國管式胰島素幫浦市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國管式胰島素幫浦市場

第19章：中國管式胰島素幫浦市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Beta Bionics, Inc.
  • Bigfoot Biomedical, Inc.
  • CeQur SA
  • Debiotech SA
  • Diabeloop SAS
  • DreaMed Diabetes Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Medtronic plc
  • Medtrum Technologies Inc.
  • Modular Medical, Inc.
  • SOOIL Developments Co., Ltd.
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • ViCentra BV
  • Ypsomed AG
Product Code: MRR-AE420CB13ABF

The Tube Insulin Pumps Market was valued at USD 4.56 billion in 2025 and is projected to grow to USD 5.09 billion in 2026, with a CAGR of 6.26%, reaching USD 6.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.56 billion
Estimated Year [2026] USD 5.09 billion
Forecast Year [2032] USD 6.98 billion
CAGR (%) 6.26%

A strategic introduction that situates tube insulin pumps within evolving diabetes care models and highlights clinical priorities, connectivity expectations, and design drivers

This report offers a focused introduction to the clinical, technological, and commercial forces shaping tube insulin pumps, outlining why this device category commands growing attention from clinicians, payers, and product developers. The opening narrative frames the patient populations most affected by continuous subcutaneous insulin delivery, highlights the shifting expectations for connectivity and user experience, and positions device innovation within the broader trajectory of diabetes management.

Moving from clinical imperatives to industry priorities, the introduction connects patient adherence challenges and outpatient care models with the imperative for interoperable systems and more intuitive user interfaces. It also clarifies distinctions across device architectures, the role of companion software, and how differentiated insulin formulations influence device engineering and dosing algorithms. By establishing this baseline, readers will gain a clear context for the subsequent sections that examine market dynamics, regulatory pressures, and strategic segmentation considerations.

How technological convergence, connectivity evolution, and shifting care models are remapping competitive advantage and patient expectations in tube insulin therapy

The landscape for tube insulin pumps is experiencing transformative shifts driven by technology convergence, regulatory evolution, and changes in care delivery. Advanced closed-loop control systems that combine continuous glucose monitoring with automated insulin delivery are maturing from experimental implementations into commercially viable options, prompting a shift in clinical workflows and patient expectations. At the same time, improvements in rapid-acting and ultra-rapid-acting insulin formulations reshape dosing strategies and reduce the time-to-action requirements for pump algorithms, thereby intensifying demand for precise delivery mechanisms and smarter control logic.

Connectivity is another inflection point: Bluetooth Classic and Bluetooth Low Energy options expand device interoperability with mobile apps and cloud platforms, while Wi-Fi enabled solutions create new opportunities for remote monitoring, data analytics, and population health management. These connectivity pathways converge with app-integrated systems that utilize mobile apps or cloud platforms to deliver insights, enable remote titration, and support adherence through data-driven coaching. Concurrently, the distribution environment is fragmenting as online pharmacies gain credibility alongside traditional hospital and retail pharmacy channels, altering procurement cycles and aftercare pathways.

From a care setting perspective, there is a clear pivot toward home-based management where caregiver-managed and self-managed regimens demand simplified user experiences and robust safety features. Hospitals and clinics, including teaching hospitals and community hospitals, continue to adopt sophisticated therapy options but seek interoperability with electronic health records and institutional procurement processes. The cumulative effect of these shifts is to raise the bar on device usability, secure data handling, and regulatory compliance, while creating commercial openings for manufacturers that can deliver clinically validated automation, seamless connectivity, and flexible distribution models.

Assessing the operational ripple effects and procurement adaptations following the cumulative trade measures instituted in the United States in 2025

The cumulative impact of tariffs enacted in the United States in 2025 has introduced measurable friction across global supply chains for medical devices, particularly for components and finished assemblies used in tube insulin pumps. Manufacturers have responded by reassessing upstream sourcing strategies, increasing emphasis on component standardization, and accelerating conversations about nearshoring or dual-sourcing critical parts. These operational adjustments aim to preserve production continuity while minimizing cost escalation, but they also require time to implement and validate under medical device quality systems.

Procurement teams within hospitals, clinic networks, and large pharmacy distributors have adjusted tender specifications to account for higher landed costs and extended lead times. These purchasing changes have prompted suppliers to offer more value-added services such as longer warranty terms, bundled maintenance, or extended training to differentiate offerings without relying solely on price. In parallel, innovation pathways have been influenced as manufacturers prioritize designs that reduce reliance on tariff-exposed components, favoring modular architectures and supplier-agnostic interfaces that facilitate component substitution.

Regulatory and reimbursement stakeholders are monitoring the downstream effects on patient access, particularly for patients who rely on public insurance or government reimbursement programs. Payers and policy makers have initiated dialogues about mitigating patient cost exposure through targeted reimbursement adjustments or by incentivizing domestic production of critical device components. Meanwhile, the elevated cost environment has catalyzed partnerships between device firms and distribution channels, including online pharmacies and chain pharmacy groups, to develop financing options and support programs intended to maintain adherence and continuity of care amid supply chain pressures.

Deep segmentation analysis revealing how product architectures, insulin formulations, care settings, distribution channels, connectivity choices, and payment pathways intersect to shape strategic priorities

A granular view of segmentation reveals nuanced performance drivers across product types, insulin formulations, end users, distribution channels, technologies, application models, and payment methods. Product differentiation matters: closed-loop pumps, studied through the lens of commercial systems and do-it-yourself systems, are altering clinical expectations by offering varying levels of automation and regulatory oversight. Conventional pumps, including iterations developed as artificial pancreas systems, continue to play a role where clinicians seek incremental automation with established device footprints. Patch pumps provide an alternative for patients prioritizing discretion and simplified attachment methods, shaping adoption curves in populations less tolerant of tubing or device bulk.

Insulin type further layers the segmentation story. Rapid-acting insulins such as aspart, glulisine, and lispro remain foundational for many delivery algorithms, while ultra-rapid-acting options including Fiasp and Lyumjev introduce opportunities to refine postprandial control and shorten onset times, compelling manufacturers to validate compatibility and dosing fidelity across formulations. End user segmentation delineates ambulatory services, home care settings, and hospitals and clinics, with home care subdivided into caregiver-managed and self-managed pathways and hospitals and clinics differentiated between community and teaching institutions. These distinctions affect training needs, service models, and the design of alerting and support systems.

Distribution channel segmentation highlights the importance of hospital pharmacies, online pharmacies, and retail pharmacies, where retail options further split into chain and independent pharmacies. Each channel imposes different expectations for stocking, warranty management, and patient education. Technology segmentation underscores connectivity choices: Bluetooth enabled devices, segmented into Bluetooth Classic and Bluetooth Low Energy, appeal to different handset profiles and energy budgets, while Wi-Fi enabled devices support continuous cloud synchronization but raise additional cybersecurity considerations. Application segmentation separates app-integrated solutions, which depend on cloud platforms or mobile apps, from standalone devices that prioritize on-device control and minimal external dependencies. Finally, payment method segmentation distinguishes insurance-covered scenarios, divided into government reimbursement and private insurance, from out-of-pocket models, a split that drives different affordability strategies and patient support mechanisms. Taken together, these segment layers create intersecting decision criteria for product development, go-to-market strategies, and clinical adoption pathways.

Regional dynamics and localized strategic imperatives that influence regulatory strategy, reimbursement alignment, and distribution partnerships across major global markets

Regional dynamics vary substantially across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography presenting distinct regulatory, reimbursement, infrastructure, and patient behavior considerations that influence product strategy and market entry approaches. In the Americas, a mature clinical ecosystem and sophisticated reimbursement frameworks incentivize advanced closed-loop and app-integrated solutions, while increasing attention to domestic manufacturing and supply chain resilience has tempered sourcing strategies. European markets balance strong clinical adoption with diverse national reimbursement systems, creating a landscape where localized evidence generation and country-specific pricing strategies are critical for uptake.

The Middle East & Africa region demonstrates divergent needs driven by uneven healthcare infrastructure and varying levels of access to specialty services, which favors solutions that emphasize robustness, ease of use, and flexible service models. In Asia-Pacific, rapid adoption in urban centers coexists with significant rural access challenges; this duality elevates the importance of scalable training, distribution partnerships, and devices capable of functioning reliably in constrained connectivity environments. Across regions, digital health policies, data privacy frameworks, and regulatory pathways for automated insulin delivery systems are evolving, necessitating tailored regulatory strategies and localized clinical validation efforts. Strategic entrants will therefore align product roadmaps with regional clinical priorities, reimbursement realities, and distribution ecosystems to optimize adoption and support sustainable patient outcomes.

Competitive landscape insights highlighting how clinical validation, interoperable ecosystems, and strategic partnerships determine leadership in the tube insulin pump sector

Competitive dynamics in the tube insulin pump landscape are shaped by established medical device manufacturers, innovative startups, and cross-industry entrants focused on digital health and software-enabled care models. Leading product developers differentiate through a combination of clinical validation, robust quality systems, and investments in interoperable platforms that integrate glucose sensors, delivery mechanisms, and data management tools. Strategic partnerships between device firms and insulin manufacturers, cloud platform providers, and pharmacy networks create ecosystems that extend value beyond the physical pump to include adherence programs, remote monitoring services, and population-level analytics.

Smaller, highly focused companies often drive rapid innovation cycles with specialized form factors or algorithmic enhancements, while larger incumbents leverage scale to navigate complex procurement processes and provide comprehensive post-market support. Collaboration between manufacturers and institutional care providers continues to accelerate iterative improvements, with clinician feedback loops informing usability refinements and alarm thresholds. Additionally, cross-sector entrants from consumer electronics and software backgrounds introduce new user experience expectations, prompting traditional device makers to prioritize intuitive interfaces, secure data exchange, and seamless firmware update mechanisms. Overall, competitive advantage accrues to organizations that can combine clinical credibility, regulatory agility, and meaningful digital services that improve patient adherence and clinical outcomes.

Practical, high-impact recommendations for manufacturers and stakeholders to strengthen resilience, accelerate adoption, and align product roadmaps with payer and clinical needs

Industry leaders should prioritize several actionable strategies to preserve and expand competitive positioning while meeting clinician and patient needs. First, invest in modular device architectures and supplier-agnostic interfaces that reduce exposure to component-specific tariffs and enable rapid substitution of critical parts. This approach supports resilience and shortens response times in the face of supply chain disruptions. Second, accelerate interoperability initiatives that allow pumps to integrate with popular mobile apps and cloud platforms, ensuring compatibility with both Bluetooth Low Energy profiles for battery efficiency and Wi-Fi for continuous data exchange where appropriate.

Third, forge closer alignment with reimbursement stakeholders to design evidence-generation plans that address regional payer requirements, including real-world outcomes and health economic data that demonstrate value beyond device acquisition. Fourth, optimize distribution strategies by deepening partnerships across hospital pharmacies, online pharmacies, and retail channels, tailoring service and training models for chain and independent pharmacy environments. Fifth, enhance patient support offerings for both caregiver-managed and self-managed home care pathways, leveraging mobile apps and cloud platforms to deliver remote training, adherence nudges, and clinical escalation protocols that reduce unnecessary hospital visits. Finally, embed cybersecurity, data privacy, and robust post-market surveillance into product roadmaps to meet regulatory expectations and protect patient trust, recognizing that these elements increasingly influence procurement decisions and long-term adoption.

Transparent and reproducible research methodology combining clinician interviews, device testing, regulatory analysis, and supply chain mapping to underpin strategic findings

The research methodology underpinning this analysis combines primary and secondary approaches to ensure a comprehensive, evidence-based view of clinical, technological, and commercial factors. Primary inputs included structured interviews with clinical endocrinologists, diabetes educators, procurement leaders across hospitals and clinics, and representatives from distribution channels, providing direct insights on device usability, training requirements, and procurement preferences. In parallel, device-level testing and technical reviews assessed compatibility across insulin formulations and connectivity modalities, with attention to battery life, dosing precision, and human factors considerations.

Secondary research encompassed a rigorous review of regulatory filings, peer-reviewed clinical studies, white papers from reputable scientific organizations, and publicly available payer and guideline documents to contextualize adoption drivers and safety considerations. Supply chain mapping identified component risk concentrations and common sourcing geographies, informing the analysis of tariff impacts and mitigation pathways. Finally, synthesis methods included cross-validation between qualitative interviews and technical assessments to surface consistent themes, and scenario-based analysis to articulate strategic implications for manufacturers, payers, and care providers.

A concise synthesis of strategic takeaways emphasizing integration of clinical validation, interoperability, and resilience to translate innovation into sustainable patient and commercial value

In summary, tube insulin pumps are at an inflection point where technological innovation, connectivity paradigms, and evolving care delivery models converge to create both opportunities and operational challenges. Closed-loop systems and app-integrated solutions promise improved glycemic control and patient convenience, while innovations in insulin formulations and device miniaturization expand options for diverse patient preferences. At the same time, external pressures such as trade policy shifts and distribution channel fragmentation necessitate deliberate choices around sourcing, modularity, and payer engagement.

Stakeholders that integrate clinical validation, robust interoperability, and region-sensitive commercialization strategies will be best positioned to translate device capabilities into sustained clinical benefit and commercial success. By focusing on resilience, payer alignment, and patient-centric service models, manufacturers and care providers can navigate near-term headwinds while unlocking long-term value for people living with diabetes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Tube Insulin Pumps Market, by Product Type

  • 8.1. Closed-Loop Pumps
    • 8.1.1. Commercial Systems
    • 8.1.2. Diy Systems
  • 8.2. Conventional Pumps
  • 8.3. Patch Pumps

9. Tube Insulin Pumps Market, by Insulin Type

  • 9.1. Rapid-Acting
    • 9.1.1. Aspart
    • 9.1.2. Glulisine
    • 9.1.3. Lispro
  • 9.2. Ultra-Rapid-Acting
    • 9.2.1. Fiasp
    • 9.2.2. Lyumjev

10. Tube Insulin Pumps Market, by Technology

  • 10.1. Bluetooth Enabled
    • 10.1.1. Bluetooth Classic
    • 10.1.2. Bluetooth Low Energy
  • 10.2. Non Connected
  • 10.3. Wi-Fi Enabled

11. Tube Insulin Pumps Market, by Payment Method

  • 11.1. Insurance Covered
    • 11.1.1. Government Reimbursement
    • 11.1.2. Private Insurance
  • 11.2. Out Of Pocket

12. Tube Insulin Pumps Market, by Application

  • 12.1. App Integrated
    • 12.1.1. Cloud Platform
    • 12.1.2. Mobile App
  • 12.2. Standalone

13. Tube Insulin Pumps Market, by End User

  • 13.1. Ambulatory Services
  • 13.2. Home Care Settings
    • 13.2.1. Caregiver-Managed
    • 13.2.2. Self-Managed
  • 13.3. Hospitals Clinics
    • 13.3.1. Community Hospitals
    • 13.3.2. Teaching Hospitals

14. Tube Insulin Pumps Market, by Distribution Channel

  • 14.1. Hospital Pharmacies
  • 14.2. Online Pharmacies
  • 14.3. Retail Pharmacies
    • 14.3.1. Chain Pharmacies
    • 14.3.2. Independent Pharmacies

15. Tube Insulin Pumps Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Tube Insulin Pumps Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Tube Insulin Pumps Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Tube Insulin Pumps Market

19. China Tube Insulin Pumps Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Beta Bionics, Inc.
  • 20.6. Bigfoot Biomedical, Inc.
  • 20.7. CeQur SA
  • 20.8. Debiotech SA
  • 20.9. Diabeloop SAS
  • 20.10. DreaMed Diabetes Ltd.
  • 20.11. F. Hoffmann-La Roche Ltd.
  • 20.12. Medtronic plc
  • 20.13. Medtrum Technologies Inc.
  • 20.14. Modular Medical, Inc.
  • 20.15. SOOIL Developments Co., Ltd.
  • 20.16. Tandem Diabetes Care, Inc.
  • 20.17. Terumo Corporation
  • 20.18. ViCentra B.V.
  • 20.19. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TUBE INSULIN PUMPS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL TUBE INSULIN PUMPS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES TUBE INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA TUBE INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY COMMERCIAL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY COMMERCIAL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY COMMERCIAL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY DIY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY DIY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY DIY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CONVENTIONAL PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CONVENTIONAL PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CONVENTIONAL PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ASPART, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ASPART, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ASPART, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY GLULISINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY GLULISINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY GLULISINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY LISPRO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY LISPRO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY LISPRO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY FIASP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY FIASP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY FIASP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY LYUMJEV, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY LYUMJEV, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY LYUMJEV, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH CLASSIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH CLASSIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH CLASSIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH LOW ENERGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH LOW ENERGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH LOW ENERGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY NON CONNECTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY NON CONNECTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY NON CONNECTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY WI-FI ENABLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY WI-FI ENABLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY WI-FI ENABLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY GOVERNMENT REIMBURSEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY GOVERNMENT REIMBURSEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY GOVERNMENT REIMBURSEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PRIVATE INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY PRIVATE INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY OUT OF POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY OUT OF POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY OUT OF POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CLOUD PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CLOUD PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CLOUD PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY MOBILE APP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY MOBILE APP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY AMBULATORY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY AMBULATORY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY AMBULATORY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CAREGIVER-MANAGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CAREGIVER-MANAGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CAREGIVER-MANAGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY SELF-MANAGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY SELF-MANAGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY SELF-MANAGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL TUBE INSULIN PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 272. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 273. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 275. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 284. GCC TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. GCC TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. GCC TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 287. GCC TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. GCC TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 289. GCC TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 290. GCC TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. GCC TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 292. GCC TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 293. GCC TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 294. GCC TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. GCC TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 296. GCC TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. GCC TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 298. GCC TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 299. GCC TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. GCC TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 304. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 306. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 308. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 310. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY HOSPITALS CLINICS, 2018-2032 (USD MILLION)
  • TABLE 316. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION TUBE INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY CLOSED-LOOP PUMPS, 2018-2032 (USD MILLION)
  • TABLE 321. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY INSULIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 323. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY ULTRA-RAPID-ACTING, 2018-2032 (USD MILLION)
  • TABLE 324. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 325. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY BLUETOOTH ENABLED, 2018-2032 (USD MILLION)
  • TABLE 326. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY PAYMENT METHOD, 2018-2032 (USD MILLION)
  • TABLE 327. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY INSURANCE COVERED, 2018-2032 (USD MILLION)
  • TABLE 328. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY APP INTEGRATED, 2018-2032 (USD MILLION)
  • TABLE 330. BRICS TUBE INSULIN PUMPS MARKET SIZE, BY END USER, 2018-2032